BTIG launched coverage of Definitive Healthcare (NASDAQ:DH) with a “buy” rating and $7 target price. The stock closed at $4.44 on September 16. Definitive Healthcare is one of the industry’s most comprehensive...
BTIG downgraded Babylon Health (NASDAQ:BBLN) to “sell” from “neutral” with a price target of zero, reflecting concerns around earnings, cash flow and cash needs, and the structure of a possible go-private transaction...
Analysts for SVB Securities and BTIG downgraded Accolade (NASDAQ:ACCD) after the company reduced the growth of its fiscal 2023 guidance to 15% year-over-year from 25% and the loss of Comcast as Accolade’s flagship...